All Studies

A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice.

The study evaluated a vaccine for allergic rhinitis and bronchial asthma, using an ultrashort treatment regimen. The vaccine showed significant reduction in symptoms and immune response polarization, suggesting potential efficacy. Further safety studies are recommended.

Babayeva M et al (2022).
Front Immunol.
PubMed:
36439113

Traditional Chinese medicine Tongxie Yaofang treating irritable bowel syndrome with diarrhea and type 2 diabetes mellitus in rats with liver-depression and spleen-deficiency: A preliminary study.

Researchers investigated the Chinese medicine Tongxie Yaofang (TXYF) in treating inflammation in rats with irritable bowel syndrome (IBS) and type 2 diabetes (T2DM). Rat models were created and given TXYF treatment, and major inflammatory factors and intestinal permeability proteins were measured through H&E staining, ELISA, and immunohistochemistry. Results show that TXYF treatment reduced inflammatory reactions and improved disease states in rats with D-IBS and T2DM. The study suggests potential benefits of TXYF in treating these conditions.

Xu W et al (2022).
Front Nutr.
PubMed:
36438735